ABBOTT LABORATORIES (ABT) Stock Overview
USA - NYSE:ABT - US0028241000 - Common Stock
ABT Key Statistics, Chart & Performance
The current stock price of ABT is 128.54 USD. In the past month the price decreased by -5.51%. In the past year, price increased by 7.66%.
ABT Latest News, Press Relases and Analysis
ABT Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 55.42 | 159.93B | ||
| BSX | BOSTON SCIENTIFIC CORP | 35.07 | 147.05B | ||
| SYK | STRYKER CORP | 29.14 | 143.14B | ||
| MDT | MEDTRONIC PLC | 17.32 | 122.86B | ||
| BDX | BECTON DICKINSON AND CO | 13.25 | 54.20B | ||
| IDXX | IDEXX LABORATORIES INC | 52.91 | 50.83B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.04 | 43.82B | ||
| RMD | RESMED INC | 28.07 | 39.13B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.89 | 33.81B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.98 | 27.46B | ||
| DXCM | DEXCOM INC | 39.18 | 26.12B | ||
| STE | STERIS PLC | 25.18 | 23.66B |
Related stock screener links
About ABT
Company Profile
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. The company is headquartered in Abbott Park, Illinois and currently employs 114,000 full-time employees. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. The company serves people in more than 160 countries.
Company Info
ABBOTT LABORATORIES
100 Abbott Park Road, Abbot Park
ABBOTT PARK ILLINOIS 60064 US
CEO: Robert B. Ford
Employees: 114000
Phone: 12246676100
ABBOTT LABORATORIES / ABT FAQ
What is the stock price of ABBOTT LABORATORIES today?
The current stock price of ABT is 128.54 USD. The price increased by 0.71% in the last trading session.
What is the ticker symbol for ABBOTT LABORATORIES stock?
The exchange symbol of ABBOTT LABORATORIES is ABT and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is ABT stock listed?
ABT stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for ABBOTT LABORATORIES stock?
35 analysts have analysed ABT and the average price target is 144.58 USD. This implies a price increase of 12.48% is expected in the next year compared to the current price of 128.54. Check the ABBOTT LABORATORIES stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ABBOTT LABORATORIES worth?
ABBOTT LABORATORIES (ABT) has a market capitalization of 223.72B USD. This makes ABT a Mega Cap stock.
How many employees does ABBOTT LABORATORIES have?
ABBOTT LABORATORIES (ABT) currently has 114000 employees.
What are the support and resistance levels for ABBOTT LABORATORIES (ABT) stock?
ABBOTT LABORATORIES (ABT) has a support level at 125.4 and a resistance level at 128.76. Check the full technical report for a detailed analysis of ABT support and resistance levels.
Is ABBOTT LABORATORIES (ABT) expected to grow?
The Revenue of ABBOTT LABORATORIES (ABT) is expected to grow by 6.48% in the next year. Check the estimates tab for more information on the ABT EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ABBOTT LABORATORIES (ABT) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ABT, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ABT, evaluating the profitability, health, valuation and growth aspects
- ABBOTT LABORATORIES (ABT) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ABBOTT LABORATORIES (ABT) Sales and EPS estimates to see what analysts future expectations are.
- ABBOTT LABORATORIES (ABT) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ABBOTT LABORATORIES (ABT) Insider and Institutional Ownership to learn about the owners and their transactions.
- ABBOTT LABORATORIES (ABT) Stock Chart to make your own analysis
- ABBOTT LABORATORIES (ABT) Latest news and press-releases to stay up to date.
Does ABBOTT LABORATORIES (ABT) stock pay dividends?
ABBOTT LABORATORIES (ABT) has a dividend yield of 1.85%. The yearly dividend amount is currently 2.21. Check the full fundamental report for a detailed analysis of ABT dividend history, reliability and sustainability.
When does ABBOTT LABORATORIES (ABT) report earnings?
ABBOTT LABORATORIES (ABT) will report earnings on 2026-01-20, after the market close.
What is the Price/Earnings (PE) ratio of ABBOTT LABORATORIES (ABT)?
The PE ratio for ABBOTT LABORATORIES (ABT) is 25.76. This is based on the reported non-GAAP earnings per share of 4.99 and the current share price of 128.54 USD. Check the full fundamental report for a full analysis of the valuation metrics for ABT.
What is the Short Interest ratio of ABBOTT LABORATORIES (ABT) stock?
The outstanding short interest for ABBOTT LABORATORIES (ABT) is 1.04% of its float. Check the ownership tab for more information on the ABT short interest.
ABT Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to ABT. When comparing the yearly performance of all stocks, ABT turns out to be only a medium performer in the overall market: it outperformed 60.62% of all stocks.
ABT Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to ABT. ABT has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
ABT Financial Highlights
Over the last trailing twelve months ABT reported a non-GAAP Earnings per Share(EPS) of 4.99. The EPS increased by 10.4% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 32.43% | ||
| ROA | 16.64% | ||
| ROE | 27.65% | ||
| Debt/Equity | 0.26 |
ABT Forecast & Estimates
35 analysts have analysed ABT and the average price target is 144.58 USD. This implies a price increase of 12.48% is expected in the next year compared to the current price of 128.54.
For the next year, analysts expect an EPS growth of 11.28% and a revenue growth 6.48% for ABT